DermTech, Inc.

OTCPK:DMTK.Q Voorraadrapport

Marktkapitalisatie: US$3.5k

DermTech Beheer

Beheer criteriumcontroles 2/4

DermTech's CEO is Bret Christensen, appointed in May 2023, has a tenure of 1.5 years. total yearly compensation is $1.93M, comprised of 20.2% salary and 79.8% bonuses, including company stock and options. directly owns 0.007% of the company’s shares, worth $0.25. The average tenure of the management team and the board of directors is 2.9 years and 3.1 years respectively.

Belangrijke informatie

Bret Christensen

Algemeen directeur

US$1.9m

Totale compensatie

Percentage CEO-salaris20.2%
Dienstverband CEO1.5yrs
Eigendom CEO0.007%
Management gemiddelde ambtstermijn2.9yrs
Gemiddelde ambtstermijn bestuur3.1yrs

Recente managementupdates

Recent updates

DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 44%

May 21
DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 44%

We're A Little Worried About DermTech's (NASDAQ:DMTK) Cash Burn Rate

Mar 02
We're A Little Worried About DermTech's (NASDAQ:DMTK) Cash Burn Rate

Investors Don't See Light At End Of DermTech, Inc.'s (NASDAQ:DMTK) Tunnel And Push Stock Down 28%

Mar 02
Investors Don't See Light At End Of DermTech, Inc.'s (NASDAQ:DMTK) Tunnel And Push Stock Down 28%

Revenues Working Against DermTech, Inc.'s (NASDAQ:DMTK) Share Price

Dec 28
Revenues Working Against DermTech, Inc.'s (NASDAQ:DMTK) Share Price

Companies Like DermTech (NASDAQ:DMTK) Could Be Quite Risky

Sep 18
Companies Like DermTech (NASDAQ:DMTK) Could Be Quite Risky

Can DermTech (NASDAQ:DMTK) Afford To Invest In Growth?

Jun 14
Can DermTech (NASDAQ:DMTK) Afford To Invest In Growth?

Need To Know: The Consensus Just Cut Its DermTech, Inc. (NASDAQ:DMTK) Estimates For 2023

May 10
Need To Know: The Consensus Just Cut Its DermTech, Inc. (NASDAQ:DMTK) Estimates For 2023

DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 37%

May 06
DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 37%

We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate

Jan 16
We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate

Analyst Forecasts Just Became More Bearish On DermTech, Inc. (NASDAQ:DMTK)

Nov 08
Analyst Forecasts Just Became More Bearish On DermTech, Inc. (NASDAQ:DMTK)

Will DermTech (NASDAQ:DMTK) Spend Its Cash Wisely?

Oct 11
Will DermTech (NASDAQ:DMTK) Spend Its Cash Wisely?

DermTech grants stock options

Oct 11

Diving Into DermTech

Sep 01

Earnings Release: Here's Why Analysts Cut Their DermTech, Inc. (NASDAQ:DMTK) Price Target To US$23.80

Aug 10
Earnings Release: Here's Why Analysts Cut Their DermTech, Inc. (NASDAQ:DMTK) Price Target To US$23.80

DermTech: Approaching An All Or Nothing Moment

Jun 13

We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate

Jun 04
We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate

DermTech - Taking A Second Look At The Growth Thesis

Mar 31

DermTech: Adoption Headwinds And Earnings Misses

Dec 23

Companies Like DermTech (NASDAQ:DMTK) Are In A Position To Invest In Growth

Dec 02
Companies Like DermTech (NASDAQ:DMTK) Are In A Position To Invest In Growth

Analyse CEO-vergoeding

Hoe is Bret Christensen's beloning veranderd ten opzichte van DermTech's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Mar 31 2024n/an/a

-US$90m

Dec 31 2023US$2mUS$389k

-US$101m

Compensatie versus markt: Bret's total compensation ($USD1.93M) is above average for companies of similar size in the US market ($USD655.65K).

Compensatie versus inkomsten: Insufficient data to compare Bret's compensation with company performance.


CEO

Bret Christensen (53 yo)

1.5yrs

Tenure

US$1,928,967

Compensatie

Mr. Bret Christensen serves as Chief Executive Officer, President and Director at DermTech, Inc. since May 08, 2023. He serves as Director of Axena Health, Inc. Mr. Christensen had been Chief Commercial Of...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Bret Christensen
President1.5yrsUS$1.93m0.0071%
$ 0.2
Kevin Sun
CFO, Treasurer & Secretary5.2yrsUS$934.85k0.57%
$ 19.9
Ray Akhavan
General Counsel3.8yrsUS$818.76k0.19%
$ 6.7
Steve Kunszabo
Senior Director of Investor Relationsno datageen gegevensgeen gegevens
Jennifer Eilemberg
Chief Compliance Officer2.3yrsgeen gegevensgeen gegevens
Loren Clarke
Chief Medical Officer3.4yrsgeen gegevensgeen gegevens
Mark Aguillard
Chief Commercial Officer1.2yrsgeen gegevensgeen gegevens

2.9yrs

Gemiddelde duur

52yo

Gemiddelde leeftijd

Ervaren management: DMTK.Q's management team is considered experienced (2.9 years average tenure).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Bret Christensen
President1.5yrsUS$1.93m0.0071%
$ 0.2
Herman Rosenman
Independent Director5.3yrsUS$149.64k0.28%
$ 9.9
Kirk Malloy
Independent Director2.3yrsUS$136.64k0.094%
$ 3.3
Matthew Posard
Independent Chairman of the Board8.3yrsUS$188.64k0.35%
$ 12.2
Mark Capone
Independent Director2.3yrsUS$139.64k0.081%
$ 2.9
Cynthia Collins
Independent Director5.3yrsUS$156.64k0.20%
$ 6.9
Nathalie Keraudy
Independent Director3.1yrsUS$134.64k0.092%
$ 3.2

3.1yrs

Gemiddelde duur

57yo

Gemiddelde leeftijd

Ervaren bestuur: DMTK.Q's board of directors are considered experienced (3.1 years average tenure).